Understanding your progress
GLP-1 Weight Loss Plateau: Why It Happens and What to Do
You started Ozempic, Wegovy, Mounjaro or another GLP-1 medication. Your appetite changed, your weight began to fall and then, weeks or months later, the scales seemed to stop moving.
It is easy to interpret this as: "My GLP-1 has stopped working."
But a slowing of weight loss is not unusual. In fact, long-term clinical trials show that weight loss with both semaglutide and tirzepatide eventually slows and reaches a plateau for many people, even when treatment continues.
The important question is therefore not simply "How do I make the scale move again?" It is: what is actually happening, and is there anything in your nutrition, movement, medication or expectations that needs reviewing?
What is a GLP-1 weight-loss plateau?
A weight-loss plateau is a period during which your overall weight trend becomes relatively stable after previously losing weight.
That is different from weighing the same for a few days.
Body weight naturally moves up and down because of changes in:
- hydration
- salt intake
- carbohydrate intake
- food still being digested
- bowel movements
- menstrual-cycle related fluid changes
- exercise and muscle inflammation
A flat scale for several days does not necessarily mean fat loss has stopped. Looking at the trend over time is more useful than reacting to individual weigh-ins.
Do people really plateau on GLP-1 medications?
Yes.
Clinical trials consistently show that GLP-1-related weight loss is not a straight line. Weight tends to fall more quickly earlier in treatment and then the rate of loss gradually slows.
What happened with semaglutide?
In the STEP 1 trial, adults taking semaglutide 2.4 mg lost an average of 14.9% of their starting body weight over 68 weeks, compared with 2.4% with placebo.
Longer-term research shows what happens after that initial period. In the SELECT trial, average body weight in participants receiving semaglutide levelled off at approximately week 65 and the treatment-associated weight difference was maintained during longer follow-up.
What happened with tirzepatide?
A post-hoc analysis of the SURMOUNT trials specifically investigated the time it took people taking tirzepatide to reach a weight plateau.
Researchers defined plateau using changes in weight across repeated 12-week periods. In SURMOUNT-1, median time to plateau varied according to starting BMI, at approximately 24 to 36 weeks. By week 72, the large majority of participants included in the analysis had reached a plateau.
A plateau does not automatically mean treatment failure
The clinical trials themselves show a slowing and eventual levelling of weight loss. Your body is not expected to continue losing the same amount every week indefinitely.
Why does weight loss slow down?
There is rarely one single explanation. Several things can be happening at the same time.
1. A smaller body generally needs less energy
As you lose weight, you are maintaining and moving a smaller body.
Your total daily energy requirements therefore tend to become lower than they were at your starting weight. The food intake that produced a substantial energy deficit earlier in your journey may produce a smaller deficit later.
This is one reason weight loss normally becomes slower over time, whether or not GLP-1 medication is involved.
2. The dramatic early loss was never going to continue forever
Some people experience a noticeable drop on the scales early in treatment. Not all of that change represents body fat.
Changes in food intake, carbohydrate stores, water and digestive contents can all influence early scale weight.
Comparing every later month with the first few weeks can therefore create unrealistic expectations about how quickly weight "should" continue falling.
3. Your eating may have changed without you noticing
GLP-1 medications can substantially reduce appetite, particularly during the earlier stages of treatment or after dose increases.
Over time, appetite may become more noticeable again. Portion sizes may gradually increase or previously avoided foods may return.
This does not mean you have failed, and it does not necessarily mean the medication has stopped working.
It can simply be a useful point to review your eating pattern rather than relying entirely on appetite suppression.
4. You may be moving less
Daily movement can change during weight loss without being obvious.
If you are tired, eating very little or generally feeling less energetic, you may walk less, sit more and reduce spontaneous movement throughout the day.
That matters because physical activity is not limited to formal workouts.
Walking, standing, household activity and everyday movement all contribute to daily energy expenditure.
5. Constipation can hide what's happening
Constipation is a common gastrointestinal problem reported with GLP-1 medications.
If bowel movements become less frequent, the number on the scale can temporarily rise or remain unchanged because of gut contents and fluid shifts.
That does not mean constipation explains every plateau, but bowel regularity is worth considering before drawing conclusions from short-term scale changes.
6. Normal water fluctuations can mask fat loss
The scales measure your total body weight. They do not directly measure body fat.
You can therefore lose some body fat while simultaneously holding more water.
This is particularly relevant after higher-salt meals, harder exercise, travel, poor sleep or around parts of the menstrual cycle.
Before trying to eat even less, review these things
When the scales stall, the instinctive response is often to cut food further.
That is not automatically the best solution, especially for someone whose appetite is already substantially suppressed.
Instead, review the foundations first.
| Review | What to look at |
|---|---|
| Weight trend | Look at several weeks rather than individual daily weigh-ins. |
| Protein | Are you including a meaningful protein source across your main meals? |
| Meal pattern | Are you eating structured meals or grazing unpredictably through the day? |
| Hydration | Has reduced appetite also caused you to drink less? |
| Fibre | Are vegetables, fruit, pulses or other fibre sources regularly included? |
| Bowels | Has constipation or reduced bowel frequency become an issue? |
| Movement | Has your walking or everyday activity dropped? |
| Strength | Are you doing resistance-based activity to help preserve muscle? |
Don't let a plateau turn into a protein problem
There is an important distinction between reducing excess energy intake and simply trying to eat as little as possible.
When appetite is very low, endlessly cutting food can make it increasingly difficult to obtain enough protein and other nutrients.
This matters during significant weight loss because body weight lost is not exclusively fat. Some lean tissue can also be lost.
Rather than responding to a plateau by immediately shrinking every meal, prioritise the nutritional quality of the food you are able to eat.
For many people, that means putting a protein source at the centre of meals, alongside vegetables or fruit, fibre-rich carbohydrates where tolerated and enough fluids.
What about exercise?
Exercise should not simply become a way of trying to burn off more calories because the scales have stalled.
During GLP-1-assisted weight loss, resistance training has another important job: providing a stimulus to maintain muscle and physical function.
Walking and general movement are valuable too. If your activity has gradually fallen because you have been tired, nauseous or eating very little, rebuilding everyday movement may be more useful than suddenly attempting punishing workouts.
Should you change your GLP-1 dose?
A plateau is not a reason to adjust medication yourself.
Ozempic, Wegovy, Mounjaro and other GLP-1 or related medications have specific dosing schedules, indications and safety considerations.
Whether a dose should change depends on factors including your current medication and dose, side effects, medical history, treatment response and the goals agreed with your clinician.
Nutrition and prescribing are different jobs
A nutrition professional can help you examine your food intake, protein, hydration, fibre, eating pattern and lifestyle. Decisions about starting, stopping or changing the dose of GLP-1 medication belong with your prescribing clinician.
Is your scale the only measure of progress?
A slower scale does not necessarily mean nothing is improving.
Depending on your individual health goals, it can also be useful to consider:
- waist measurements
- how your clothes fit
- strength and physical function
- energy levels
- fitness
- eating habits
- blood pressure or metabolic markers monitored by your healthcare team
The aim of GLP-1 treatment is not simply to make the number on the scale fall as quickly as possible.
For long-term health, what you preserve and build while losing weight matters too.
A practical GLP-1 plateau check
If your weight appears to have stopped moving, work through this before assuming something has gone wrong:
- Look at the trend. Has your average weight genuinely been stable, or are you reacting to a handful of readings?
- Check your meals. Has your eating pattern gradually changed?
- Check your protein. Make sure eating less has not turned into eating nutritionally poorly.
- Check hydration and fibre. Particularly if constipation has increased.
- Check your movement. Has your everyday activity fallen?
- Include strength work. Think about preserving muscle, not just reducing scale weight.
- Consider other measures. Waist, strength and how you feel can add context to scale weight.
- Speak to your prescriber when appropriate. Especially if you are concerned about treatment response, side effects or medication dosing.
The bottom line
A GLP-1 weight-loss plateau does not automatically mean your medication has stopped working.
Weight loss typically slows as treatment continues, and plateaus have been observed in major trials of both semaglutide and tirzepatide.
When that happens, avoid immediately responding by trying to eat as little as possible.
Instead, step back and look at the whole picture: your weight trend, nutrition, protein intake, hydration, bowel habits, movement, strength and overall health goals.
A plateau may be a signal that your strategy needs reviewing. It is not evidence that you have failed.
Take the guesswork out of eating on GLP-1
The GLP-1 Success Method™ gives you practical tools for protein, meals, hydration and everyday nutrition so you can build habits that support your progress beyond the number on the scale.
Explore the GLP-1 Success Method™Frequently asked questions
Is it normal to hit a weight-loss plateau on GLP-1 medication?
Yes. Weight loss does not normally continue at the same rate indefinitely. Clinical trials of semaglutide and tirzepatide show that average weight loss slows and eventually reaches a plateau even while treatment continues.
Why have I stopped losing weight on Ozempic, Wegovy or Mounjaro?
There may not be one single reason. As body weight falls, energy requirements generally fall too. Food intake and appetite can change over time, while water retention, constipation, menstrual-cycle changes and reduced activity can all influence what you see on the scale.
Does a plateau mean my GLP-1 has stopped working?
Not necessarily. Plateaus occur during long-term GLP-1 treatment in clinical trials. A period of stable weight should be looked at in the context of your overall treatment response rather than interpreted automatically as medication failure.
How long does a GLP-1 weight-loss plateau last?
There is no universal timeframe. People respond differently, and a true long-term plateau is different from a few days or weeks of normal scale fluctuation. Your longer-term weight trend gives more useful information than any individual reading.
Should I eat less if I stop losing weight on GLP-1?
Not automatically. If your appetite is already very low, reducing food further can make adequate protein and nutrient intake harder. Review the quality and structure of your diet, movement, hydration and overall progress before assuming that simply eating less is the answer.
Should I increase my Ozempic, Wegovy or Mounjaro dose?
Do not change the dose yourself because of a weight plateau. Medication decisions should be made with your prescribing clinician based on your medication, current dose, side effects, medical history and treatment response.
Can constipation make it look like my weight has stalled?
Yes. Changes in bowel frequency and gut contents can temporarily influence scale weight. If constipation has become a problem, hydration, fibre intake, movement and appropriate medical advice should be considered rather than interpreting the scale in isolation.
References
1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989-1002. doi:10.1056/NEJMoa2032183
2. Ryan DH, Lingvay I, Colhoun HM, et al. Long-term semaglutide treatment and changes in body weight and glycaemia in the SELECT trial. Diabetes Care. 2024. PubMed
3. Horn DB, Almandoz JP, Look M, et al. Time to weight plateau with tirzepatide treatment in the SURMOUNT-1 and SURMOUNT-4 clinical trials. PMC
4. Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. N Engl J Med. 2025;393:26-36. doi:10.1056/NEJMoa2416394
5. Garvey WT, Batterham RL, Bhatta M, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022;28:2083-2091. PubMed
This article is for general educational purposes and is not a substitute for individual medical advice. Evoren content is produced by a Qualified Nutritional Therapist and does not prescribe, recommend, or adjust medication. Decisions about GLP-1 medications, including dose changes, should always be made with your prescribing clinician or another appropriately qualified healthcare professional.